Skip to main content

Kinnate Biopharma Inc.

KNTEDelisted Apr 3, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001797768

Kinnate Biopharma Inc. was delisted on Apr 3, 2024; its insiders filed their last Form 4 on Apr 5, 2024; 56 institutions reported holding it in 13F filings for Q1 2024, worth $92.2M in total; Viking Global Investors was the only superinvestor holding it.

Members of Congress who traded KNTE

No member of Congress has reported a trade in Kinnate Biopharma Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.